“Zanolimumab (Humax-CD4), a Fully Human Monoclonal Antibody With Significant Clinical Responses in Cutaneous T-Cell Lymphoma”. Hematology Meeting Reports 3, no. 1 (June 11, 2009). Accessed April 26, 2026. https://journals.pagepress.net/hmr/article/view/540.